You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 287 No. 6, February 13, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related articles
 •Similar articles in JAMA

Reforming Graduate Medical Education

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Johns1 addressed many of the reasons why graduate medical education (GME) needs to be reformed. There are 2 additional issues that can readily be addressed and must be resolved if GME is to be truly reformed.

First, I agree with Relman2 that the money and thus the influence of the pharmaceutical industry must be totally removed from GME. If the pharmaceutical industry really intends to "play a leading role in sponsoring continuing medical education,"3 then perhaps they would be willing to give a few billion of the 16 billion dollars per year4 they spend on marketing directly to academic medical centers as unrestricted educational grants so that the fiscal problems provoked by the Balanced Budget Act of 1997 can be ameliorated.

The second issue is the need to rationalize the work hours and the supervision of residents,5 in order to prevent medical errors.6 A significant cause . . . [Full Text of this Article]


RELATED LETTER

Industry Strongly Supports Continuing Medical Education
Alan F. Holmer
JAMA. 2001;285(15):2012-2014.
EXTRACT | FULL TEXT  

RELATED ARTICLES

The Time Has Come to Reform Graduate Medical Education
Michael M. E. Johns
JAMA. 2001;286(9):1075-1076.
EXTRACT | FULL TEXT  

Separating Continuing Medical Education From Pharmaceutical Marketing
Arnold S. Relman
JAMA. 2001;285(15):2009-2012.
EXTRACT | FULL TEXT  

Industry Strongly Supports Continuing Medical Education
Alan F. Holmer
JAMA. 2001;285(15):2012-2014.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.